Literature DB >> 3701096

Infections after craniotomy: a retrospective study.

B van Ek, F P Bakker, H van Dulken, B A Dijkmans.   

Abstract

A retrospective study was performed to evaluate the rate of infection directly related to craniotomy. Of 246 craniotomies performed in 1981, 234 could be evaluated. The overall incidence of infection was 8.1% (19 infections in 18 patients). The infection rate was 15.2% after insertion of a ventricular shunt (seven infections after 45 ventriculostomies). Staphylococcus aureus, Staphylococcus epidermidis and Propionibacterium acnes were the most frequent isolated micro-organisms. We recommended a double-blind prospective study to evaluate the possible benefit of antibiotic prophylaxis in craniotomies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3701096     DOI: 10.1016/s0163-4453(86)93483-3

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  4 in total

1.  Post-operative central nervous system infections after cranial surgery in China: incidence, causative agents, and risk factors in 1,470 patients.

Authors:  R Zhan; Y Zhu; Y Shen; J Shen; Y Tong; H Yu; L Wen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-12-05       Impact factor: 3.267

2.  Postoperative wound dealing and superficial surgical site infection in open radical prostatectomy.

Authors:  Fukashi Yamamichi; Katsumi Shigemura; Mauso Yamashita; Kazushi Tanaka; Soishi Arakawa; Masato Fujisawa
Journal:  Int Wound J       Date:  2014-09-04       Impact factor: 3.315

3.  Effect of 4% chlorhexidine gluconate predisinfection skin scrub prior to hepatectomy: a double-blinded, randomized control study.

Authors:  Ching-Shui Hsieh; Hsiu-Chi Cheng; Jen-Shiou Lin; Shou-Jen Kuo; Yao-Li Chen
Journal:  Int Surg       Date:  2014 Nov-Dec

4.  Intra-operative antibiotic prophylaxis in neurosurgery. A prospective, randomized, controlled study on cefotiam.

Authors:  T Gaillard; J M Gilsbach
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.